首页> 外文OA文献 >Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients
【2h】

Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients

机译:巨噬细胞迁移抑制因子(mIF)在异基因造血干细胞移植受者急性移植物抗宿主病(GVHD)中的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Graft-versus-host disease (GVHD) is a major complication after hemopoietic stem cell transplantation (HSCT), but its pathogenesis remains uncertain. Macrophage migratory inhibitory factor (MIF) is an important mediator in the allo-immune reaction during renal transplantation, yet its role in hemopoietic stem cell transplantation (HSCT) remains unexplored. This study investigated the potential role of MIF in acute graft-versus-host disease (aGVHD) following allogeneic HSCT. Forty-six randomly selected patients undergoing autologous or allogeneic HSCT were studied. Immunohistochemistry and in situ hybridization were performed to examine tissue MIF mRNA and protein expression on skin and colonic biopsy specimens. The associated T cell and macrophage activation was also studied by immunohistochemical studies. A semi-quantitative method was used to assess MIF staining, as well as T cell and macrophage staining. Serial blood samples were analyzed by ELISA for serum MIF levels. Immunohistochemistry and in situ hybridization performed in 15 skin and 19 colonic biopsies from 17 patients who developed moderate to severe aGVHD showed a significant increase in MIF mRNA and protein expression compared with normal controls (seven skin and five colonic biopsies). MIF was localized within the epidermis and the vascular area of skin, but diffusely expressed in the entire thickness of colon. Macrophage and T lymphocyte infiltration was confined to areas of strong MIF expression. Serial analysis by ELISA showed that only patients who developed aGVHD (n = 19) exhibited an increase (two- to three-fold) in serum MIF during HSCT, but not in the allogeneic HSCT recipients without aGVHD (n = 7) or those who received autologous HSCT (n = 8). In 14 out of 19 patients, serum MIF peaked before the onset of aGVHD. Local and systemic up-regulation of MIF expression is associated with the occurrence of acute GVHD. Its pathogenetic role remains to be further determined.
机译:移植物抗宿主病(GVHD)是造血干细胞移植(HSCT)后的主要并发症,但其发病机理仍不确定。巨噬细胞迁移抑制因子(MIF)是肾移植过程中同种免疫反应的重要介体,但其在造血干细胞移植(HSCT)中的作用尚待探索。这项研究调查了异基因HSCT后MIF在急性移植物抗宿主病(aGVHD)中的潜在作用。研究了四十六名随机选择接受自体或异基因HSCT的患者。进行了免疫组织化学和原位杂交以检查皮肤和结肠活检标本上的组织MIF mRNA和蛋白质表达。还通过免疫组织化学研究了相关的T细胞和巨噬细胞活化。半定量方法用于评估MIF染色以及T细胞和巨噬细胞染色。通过ELISA分析系列血样的血清MIF水平。免疫组化和原位杂交在17例中度至重度aGVHD患者中进行了15例皮肤和19例结肠活检,与正常对照(7例皮肤和5例结肠活检)相比,MIF mRNA和蛋白表达显着增加。 MIF定位在表皮和皮肤血管区域内,但在结肠的整个厚度中弥散表达。巨噬细胞和T淋巴细胞浸润仅限于MIF强烈表达的区域。 ELISA序列分析显示,只有发生aGVHD的患者(n = 19)在HSCT期间血清MIF升高(2-3倍),而没有aGVHD的同种异体HSCT接受者(n = 7)或那些收到自体HSCT(n = 8)。 19名患者中有14名在aGVHD发作之前血清MIF达到峰值。 MIF表达的局部和全身上调与急性GVHD的发生有关。其致病作用有待进一步确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号